Skip to main content
. 2021 Aug 26;10:322–330. doi: 10.1016/j.xjtc.2021.08.030

Table 2.

Indication and management characteristics of patients

Variable All subjects
Preclosure used
Surgical removal
P value
n = 99 n = 51 n = 48
Indication for VA-ECMO .369
 Left heart failure 87 (87.9) 44 (86.3) 43 (89.6)
 Right heart failure 6 (6.1) 5 (9.8) 1 (2.1)
 Acute pulmonary embolism 6 (6.1) 3 (5.9) 3 (6.3)
Management considerations
 Cardiopulmonary resuscitation ongoing 18 (18.2) 4 (7.8) 14 (29.3) .008
 Arterial cannula size (Fr) 17 (17, 19) 17 (17, 19) 17.5 (17, 19) .421
 Ipsilateral arterial and venous catheters 87 (87.9) 46 (90.2) 41 (85.4) .546
 Percutaneous Impella 31 (32.3) 18 (35.3) 13 (27.1) .387
 Time spent on ECMO (d) 6 (5, 9) 6 (5, 9) 6 (4.5, 9) .919
Surgeon performing cannulation .047
 A 7 1 6
 B 11 5 6
 C 15 11 4
 D 44 24 20
 E 12 8 4
 F 7 2 5
 OSH 3 0 3

Values are presented as median (25th percentile, 75th percentile) or n (%). VA-ECMO, Venoarterial extracorporeal membrane oxygenation; OSH, outside hospital.

Abiomed, Danvers, Mass.

Surgeon identified by coded letter, where n reflects the number of procedures performed.